文献速递心律失常冠心病

神经丝轻链与房颤患者卒中风险

Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation.
PubMed 文献 · Circulation · 2024-07-24

该观察性研究利用ACTIVE A和AVERROES试验中3077例未接受口服抗凝的房颤患者基线血浆,分析神经丝轻链(NFL)与卒中及死亡风险的关联,中位随访1.5年。结果显示NFL每翻倍,卒中或系统性栓塞风险独立升高(HR 1.27,95%CI 1.10-1.46),并与心血管死亡和全因死亡独立相关;NFL联合临床信息及NT-proBNP、hs-cTnT可改善风险判别(C指数0.727)。

要点

  • NFL每翻倍,卒中或系统性栓塞风险独立升高27%(HR 1.27,95%CI 1.10-1.46)。
  • NFL与心血管死亡和全因死亡独立相关,且无卒中史患者中仍显著。
  • NFL联合临床信息、NT-proBNP和hs-cTnT可使卒中风险判别C指数达0.727。

核心结论

  • 血浆NFL反映显性和隐匿性脑缺血,可改善未抗凝房颤患者的卒中和死亡风险评估。
  • NFL与年龄、卒中史及其他生物标志物联合,可作为未来房颤卒中风险评估的探索方向。

研究设计与样本

  • 观察性研究,基线血浆来自ACTIVE A和AVERROES随机试验中3077例未接受口服抗凝的房颤患者。
  • NFL采用单分子阵列(Simoa)检测,中位随访1.5年,用Cox回归分析结局关联。

主要发现

  • 联合队列中NFL中位水平为16.9 ng/L(四分位距11.1-26.5 ng/L),中位年龄71岁,58%为男性,13%有卒中史。
  • NFL与高龄、较高肌酐、较低体重指数、既往卒中、女性及糖尿病相关,但与心律无关。
  • NFL每翻倍,卒中或系统性栓塞(n=206)风险独立于临床特征(HR 1.27,95%CI 1.10-1.46)和其他生物标志物(HR 1.18,95%CI 1.01-1.37)升高。
  • 无既往卒中患者中,NFL每翻倍卒中风险仍升高(HR 1.23,95%CI 1.02-1.48)。
  • NFL独立与心血管死亡(n=219)和全因死亡(n=311)相关;仅用NFL的卒中C指数为0.642,联合临床信息、NT-proBNP和hs-cTnT后C指数为0.727。

关键数值与推荐

  • NFL每翻倍与卒中或系统性栓塞的校正HR为1.27(95%CI 1.10-1.46)。
  • NFL每翻倍与卒中或系统性栓塞的HR在进一步校正其他生物标志物后为1.18(95%CI 1.01-1.37)。
  • 无既往卒中患者中NFL每翻倍与卒中的HR为1.23(95%CI 1.02-1.48)。
  • 仅用NFL的卒中C指数为0.642;联合临床信息、NT-proBNP和hs-cTnT的C指数为0.727。

临床怎么用

  • 在未接受口服抗凝的房颤患者中,可考虑检测血浆NFL以辅助卒中和死亡风险评估。
  • NFL可与年龄、卒中史、NT-proBNP和hs-cTnT等联合,用于优化房颤卒中风险分层。

局限性

  • 研究为观察性设计,基线血浆来自两项随机试验中随机分配至阿司匹林的患者。
  • 中位随访仅1.5年,NFL的临床效用仍需前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Biomarkers reflecting brain injury are not routinely used in risk assessment of stroke in atrial fibrillation (AF). Neurofilament light chain (NFL) is a novel biomarker released into blood after cerebral insults. We investigated the association between plasma concentrations of NFL, other biomarkers, and risk of stroke and death in patients with AF not receiving oral anticoagulation. METHODS: For this observational study, baseline plasma samples were available from 3077 patients with AF randomized to aspirin in ACTIVE A (Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events; 2003 to 2008) and AVERROES (Apixaban Versus Acetylsalicylic Acid [ASA] to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment; 2007 to 2009). Median follow-up was 1.5 years. NFL was analyzed with a Single Molecule Array (Simoa). Associations with outcomes (total stroke or systemic embolism, ischemic stroke, cardiovascular death, and all-cause death) were explored with Cox regression models. RESULTS: In the combined cohort, the median NFL level was 16.9 ng/L (interquartile range, 11.1-26.5 ng/L), the median age was 71 years, 58% were men, and 13% had a history of previous stroke. NFL was associated with older age, higher creatinine, lower body mass index, previous stroke, female sex, and diabetes but not cardiac rhythm. Higher NFL was associated with a higher risk of stroke or systemic embolism (n=206) independently of clinical characteristics (hazard ratio, 1.27 [95% CI, 1.10-1.46] per doubling of NFL) and other biomarkers (hazard ratio, 1.18 [95% CI, 1.01-1.37]) and including in patients without previous stroke (hazard ratio, 1.23 [95% CI, 1.02-1.48]). NFL was also independently associated with cardiovascular (n=219) and all-cause (n=311) death. The C index for stroke using only NFL was 0.642, on par with the currently used clinical risk scores. Addition of information on NFL improved discrimination in a model also including clinical information, NT-proBNP (N-terminal pro-B-type natriuretic peptide), and high-sensitivity cardiac troponin T, yielding a C index of 0.727. CONCLUSIONS: NFL reflects overt and covert episodes of cerebral ischemia and improves risk assessment of stroke and death in patients with AF without oral anticoagulation, including in patients without previous stroke. The combination of NFL with information on age, history of stroke, and other biomarkers should be explored as a future avenue for stroke risk assessments in patients with AF.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Aulin, Sjölin, Lindbäck, et al. Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation. Circulation. 2024. PMID: 39045686. doi:10.1161/CIRCULATIONAHA.124.069440

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。